Epstein-Barr Virus Protein Hijacks Cellular RNA Machinery
The BRRF1 protein disrupts host miRNA function by binding to the CCR4-NOT complex to trigger transcript degradation.
Updated on Oct. 26, 2026 in Life Sciences
Researchers have identified that the Epstein-Barr virus protein BRRF1 regulates post-transcriptional RNA by interacting with the cellular CCR4-NOT complex. This study establishes a mechanism by which the virus interferes with host cell miRNA function to alter transcript stability.
Why it matters
Understanding how Epstein-Barr virus proteins subvert cellular machinery provides insight into how the virus manipulates host gene expression to sustain infection. This discovery identifies specific viral-host protein interactions that could serve as future points for therapeutic intervention.
Affinity purification-mass spectrometry mapped the interaction between BRRF1 and the CCR4-NOT complex. Expression analysis showed that BRRF1 expression causes polyadenylation-dependent destabilization of transcripts and specific downregulation of Claudin 6.
The players
Epstein-Barr virus
A human herpesvirus known for establishing lifelong latent infections and manipulating host gene expression.
CCR4-NOT complex
A conserved multi-subunit protein machine that controls gene expression by regulating mRNA deadenylation and decay.
The details
BRRF1 protein localizes to cellular processing bodies, which are cytoplasmic aggregates where mRNA decay occurs. The protein binds to the CNOT9 subunit of the CCR4-NOT complex, a major deadenylase that shortens the poly-A tail of mRNA. When BRRF1 interacts with the complex, it interferes with miRNA function and triggers the destabilization of target transcripts.
The Tech Race
This study aligns with broader efforts to map the viral-host protein interactome to understand pathogenesis. It builds upon established knowledge of the CCR4-NOT complex to clarify how specific viral proteins repurpose this cellular machinery.
This research is currently in the laboratory discovery phase and does not yet affect clinical practice or patient care. Further research is required to determine if these specific interactions can be targeted with small molecules or other therapeutic modalities.
The takeaway
The study defines the molecular interface between BRRF1 and host deadenylation machinery, revealing how Epstein-Barr virus destabilizes specific transcripts. Researchers should now watch for follow-up studies investigating whether interfering with this BRRF1-CNOT9 binding reduces viral efficiency in host cells.
Further reading
For more on how viruses modify cellular processes, browse the Life Sciences section.
Source note: This article includes information reported by Journal of Virology.
